BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36525216)

  • 1. Current Developments in the Preclinical and Clinical use of Natural Killer T cells.
    Kratzmeier C; Singh S; Asiedu EB; Webb TJ
    BioDrugs; 2023 Jan; 37(1):57-71. PubMed ID: 36525216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic strategies targeting natural killer T cell responses in cancer.
    Shissler SC; Bollino DR; Tiper IV; Bates JP; Derakhshandeh R; Webb TJ
    Immunogenetics; 2016 Aug; 68(8):623-38. PubMed ID: 27393665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells.
    Webb TJ; Bieler JG; Schneck JP; Oelke M
    J Immunol Methods; 2009 Jul; 346(1-2):38-44. PubMed ID: 19446558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in Natural Killer T Cell-Based Immunotherapy for Cancer: Use of Allogeneic and Gene-Edited Cells.
    Aoki T; Motohashi S
    Crit Rev Oncog; 2024; 29(1):1-9. PubMed ID: 38421710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity.
    Kato S; Berzofsky JA; Terabe M
    Front Immunol; 2018; 9():314. PubMed ID: 29520281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach.
    Krijgsman D; Hokland M; Kuppen PJK
    Front Immunol; 2018; 9():367. PubMed ID: 29535734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I natural killer T cells: naturally born for fighting.
    Tan JQ; Xiao W; Wang L; He YL
    Acta Pharmacol Sin; 2010 Sep; 31(9):1123-32. PubMed ID: 20694020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer and NKT cells in the male reproductive tract.
    Duan YG; Gong J; Yeung WSB; Haidl G; Allam JP
    J Reprod Immunol; 2020 Nov; 142():103178. PubMed ID: 32739646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer T cell anergy, co-stimulatory molecules and immunotherapeutic interventions.
    Singh AK; Gaur P; Das SN
    Hum Immunol; 2014 Mar; 75(3):250-60. PubMed ID: 24373798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer T cells in lipoprotein metabolism and atherosclerosis.
    Getz GS; Vanderlaan PA; Reardon CA
    Thromb Haemost; 2011 Nov; 106(5):814-9. PubMed ID: 21946866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKT Cells Contribute to the Control of Microbial Infections.
    Vogt S; Mattner J
    Front Cell Infect Microbiol; 2021; 11():718350. PubMed ID: 34595131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKT-cell glycolipid agonist as adjuvant in synthetic vaccine.
    Liu Z; Guo J
    Carbohydr Res; 2017 Nov; 452():78-90. PubMed ID: 29080431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of NKT cells in gastrointestinal cancers.
    Burks J; Olkhanud PB; Berzofsky JA
    Oncoimmunology; 2022; 11(1):2009666. PubMed ID: 36524208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer T cells and atherosclerosis: form and function meet pathogenesis.
    Braun NA; Covarrubias R; Major AS
    J Innate Immun; 2010; 2(4):316-24. PubMed ID: 20375560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
    Zahran AM; Abdel-Rahim MH; Elsayh KI; Hassanien MM; Mahran SA; Hetta HF
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):161-169. PubMed ID: 30944972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
    Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
    Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of CD3/CD16/CD56 positive NKT cells in HIV/AIDS: the pilot study.
    Khvedelidze M; Chkhartishvili N; Abashidze L; Dzigua L; Tsertsvadze T
    Georgian Med News; 2008 Dec; (165):78-83. PubMed ID: 19124922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contrasting roles of NKT cells in tumor immunity.
    Berzofsky JA; Terabe M
    Curr Mol Med; 2009 Aug; 9(6):667-72. PubMed ID: 19689293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections, Reactions of Natural Killer T Cells and Natural Killer Cells, and Kidney Injury.
    Uchida T; Seki S; Oda T
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut.
    Marrero I; Maricic I; Feldstein AE; Loomba R; Schnabl B; Rivera-Nieves J; Eckmann L; Kumar V
    Front Immunol; 2018; 9():2082. PubMed ID: 30254647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.